Ads will show products displaying SAHPRAs logo claiming to be approved by them
Stay nerdy, Sean Overin, PT Subscribe to our newsletter Every Friday we cover must read studies, how they fit in practice, give it real world context, provide top resources and one sticky idea
Ngo TTD, Lea RA, Maksemous N et al
The following is derived from the clinical research literature and community protocols: Loading phase (tanning goal): Start: 0.1 mg to assess tolerance Escalate to 0.25 mg daily over 24 weeks Combine with 1020 minutes of UV exposure for accelerated pigmentation Maintenance (after desired pigmentation): 0.51 mg once or twice weekly Continue periodic UV exposure to maintain tan Sexual function dosing: Doses in the 0.251 mg range are used for acute sexual function effects, typically administered 3090 minutes before activity The Wessells 1998 study used weight-based dosing (~0.025 mg/kg, approximately 2 mg for an 80 kg individual) MT-II is supplied as lyophilized powder requiring reconstitution

Data products designed for citation and peer review A central design principle for the Retatrutide Endocrine Dynamics Framework is that the outputs must be citable, inspectable, and reusable by the wider research community, even though the underlying work is commissioned and conducted by a private supplier